Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elagolix in pre-menopausal women with heavy uterine bleeding and uterine fibroids
NCT01441635Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Sep 2011
- Primary completion
- Nov 2013
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of elagolix in Uterine Fibroids (UF), sponsored by AbbVie Inc.. Started Sep 2011; status: completed.
02
Drugs
elagolix
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT01441635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01441635.